CEO SUMMARY: For the first time in recent memory, a year has passed without major tumult or disruptive change in the laboratory industry. Our list of the Top Ten Most Important Stories of 2008 reflects a rather quiet year when compared to most years of this decade. However, events continue to unfold in healthcare and
Tag: medical tests
Chairman and CEO Mark Chandler recently disclosed that researchers within Luminex Corporation are developing new detection capabilities that would permit its LabMap system to “simultaneously perform a broad range of cellular, microbial, and related tests, such as complete blood counts (CBC) and bacterial analysis. The company recently filed an initial patent application covering aspects of
FOR THE SECOND TIME IN eight weeks, the Wall Street Journal (WSJ) has a printed a prominent story about trends in laboratory testing.
Last Friday, June 8, 2001, the WSJ’s “Health Journal” column featured a story entitled “Patients Bypass Doctors to Get Medical Tests Directly From Labs.” Trigger to this story was the fact that Quest
MCKESSON HBOC ACQUIRES ABATON.COM IN MOVE TO WEB SERVICES
IT WAS VALIDATION OF A PREDICTION made just weeks ago in THE DARK REPORT that web-based information management systems is the next major battleground in both healthcare and the clinical lab industry.
McKesson HBOC announced its purchase of Abaton.com, Inc. of Minneapolis, Minnesota last Tuesday. Abaton.com offers products
CEO SUMMARY: News that a phlebotomist employed by SmithKline Beecham Clinical Laboratories (SBCL) was discovered to be washing and reusing needles got national media attention last week. During her 22-month employment at SBCL, this phlebotomist apparently reused butterfly needles on “difficult to draw” patients. Ramifications of this discovery will affect not only SBCL, but the
CEO SUMMARY: As the laboratory industry undergoes fundamental change, new business and management models must be developed. Our list of “Movers and Shakers” for 1998 highlights individuals now leading the science of laboratory management toward these new paradigms.
FINDING EXAMPLES OF LEADERSHIP and innovation among executives and managers within the clinical laboratory industry can be a
CEO SUMMARY: Commercial laboratories are recognizing declines in the market value of their assets. LabCorp has yet to do the same. Taken cumulatively, these write-downs demonstrate the sizable revenue erosion that large commercial laboratories experienced during the past three years. Soon it will be LabCorp’s turn to address this issue.
MORE THAN $550 MILLION of clinical